- Journal Description
- Types of Submissions
- Submission Deadlines
- Peer Review Process
- Manuscript Preparation
- Editorial Policies for Authors
- Publication Ethics and Policies
- Author Fees
- Copyright Assignment
- Author Rights
- Self-Archiving Policy
- Social Media
The CAND Journal (CANDJ) is the official peer reviewed publication of the Canadian Association of Naturopathic Doctors (CAND). Published online four times per year, the CANDJ’s mission is to connect the evidence-informed best practices of the naturopathic profession to members, health care practitioners (conventional and integrative), health care stakeholders, government, and the general public. The Journal encourages submissions on a wide variety of topics in naturopathic medicine, including whole systems approaches, traditional & complementary medicine (T&CM) and integrative medicine, community and planetary health, and health equity. Learn More.
CANDJ recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Before submitting your manuscript, please read the guidelines below. Please note that manuscripts not conforming to these guidelines may be returned to the author.
Please also be sure to look over the Journal’s submission checklist before submitting.
Once ready to submit, visit our “Submit Manuscript” page to upload your submission to our online system. The Journal uses Open Journal Systems (OJS) as our online submission and peer review system. For instructions on how to submit your manuscript through the OJS system, please visit our “Submission Instructions & Process” page.
TYPES OF SUBMISSIONS
Outlined below are the types of submissions accepted to CANDJ, along with suggestion word count, figures, tables and reference limits for each. For further details about the requirements of each article type, view the “Manuscript Preparation” section.
|Article Type||Description||Suggested Word Count Limit (Excluding Abstract, Tables and References)||Other|
|Original Research*||Investigations and original research that represent new and significant contributions and advances to the field. Includes clinical trials.||3000-4000||4–6 Tables/figures and a limit of 50 references where appropriate|
|Reviews*||Reviews of major areas or sub-areas in the field. Describes new developments, summarizes progress, or analyzes published evidence. Includes narrative reviews, systematic reviews, and meta-analyses.||Up to 4000||4–6 Tables/figures and a suggested 75-reference limit|
|Editorial||Lead Editorial for the issue, typically by the Editor-in-Chief, who may call on other members of the Editor Staff or Editorial Board from time to time.||1500||1–2 Tables/figures and 4–8 references|
|Guest Editorials||Comments from recognized experts on a specific topic and related to an article published in the same issue. Editorials are generally solicited by the Editorial Staff.||1500||1–2 Tables/figures and 4–8 references|
|Commentaries||Opinions/views of recognized experts that are meant to be brief reflective pieces, calls for action and/or critiques. Commentaries are unrelated to a specific article and provide an opinion or view on a specific topic. Commentaries can address timely issues in the field.||1500||1–2 tables/figures and 4–8 references|
|Position Statements||Definitive positions taken by CAND or CAND-mandated committees on areas of clinical importance for which there is a need of guidance on clinical practice, best practices and standards, and therapeutic management. At this time the Journal does not accept position statements from outside groups or organizations.||3000||4–6 Tables/figures and a suggested 50-reference limit|
|Short Reports*||Brief reports of preliminary or limited results of original research or observations. The intent is to provide a forum for smaller scale research projects that would not meet the review standards of full-length Original Research manuscripts but would still provide a valuable contribution to the academic literature.||2000||2–4 Tables/figures and 15–20 references|
|Case Reports*||Interesting or unusual cases seen, which have the potential to be instructive for those practicing in the field.||1500||3–6 Tables/figures and 25 references|
|Perspectives*||Focused articles on topics of interest to a broad naturopathic audience but written from a personal viewpoint. Articles take the form of a review that provides the reader with an overview and background of the subject, gives personal insight into the advances and challenges, discusses opposing viewpoints, and makes recommendations for further investigation or actions. Different from a review, the Editors expect such pieces are forward-looking, thought-provoking, and informative about emerging ideas, treatments, and trends.||Up to 3000||4–6 Tables/figures and a suggested 30-reference limit|
|Letters to the Editor||Comments on work previously published in CANDJ. Letters must be submitted within one month of the online publication date of the article discussed to be considered. The Editors may invite a reply to the letter by the original author. The Editor may also consider publication of a letter that comments on other matters of interest to naturopathic medicine. This section is not considered to be an appropriate venue for publishing new data without peer review.||Up to 750||Should not have tables or figures, and no more than 5 references|
* Peer Reviewed Article Type
When planning your contributions to the Journal, please note the following submission deadline dates in order to be considered for inclusion in an upcoming issue.
|Issue||Publication Month||Submission Deadline|
|Volume 29, Number 1 (2022)||March||December 1, 2021|
|Volume 29, Number 2 (2022)||June||March 1, 2022|
|Volume 29, Number 3 (2022)||September||June 1, 2022|
|Volume 29, Number 4 (2022)||December||September 1, 2022|
PEER REVIEW PROCESS
All manuscripts are to be submitted to CANDJ’s online submission system. The submitting author will receive an automated acknowledgment by email confirming the manuscript submission.
Manuscripts will first be screened by the Editorial Assistant to determine whether they are properly prepared according to the Journal’s manuscription preparation requirements. Manuscripts that do not do not meet the standards of the Journal will be returned to the authors for revision and resubmission.
Once manuscript preparation requirements are met, the Editorial Staff will make a first assessment of the manuscript submitted and check whether it fits the aims and scope of the Journal and is of sufficient academic quality.
Where papers are not considered suitable for peer review, authors will be notified promptly of the reason so that the work can be submitted elsewhere as appropriate.
Papers that pass the initial assessment by the Editorial Staff are sent to the Peer Review stage. All manuscripts at this stage (except for Editorials, Guest Editorials, Commentaries, Letters to the Editor, and CAND Position Statements) will be sent out for review and at least two review reports per manuscript will be collected. Reviewers will be asked to complete their review within three weeks and extensions may be granted on request.
If an article is rejected for publication, or if after two rounds of revisions the author(s) and reviewers are not able to come to agreement over acceptability for publication, a third reviewer may be assigned at the discretion of the Editorial Staff or on request of the author. If requested by the author, both parties agree that the decisions after that third review will be final.
Authors should expect to receive an initial decision on their manuscript within 2–8 weeks of submission. If revision of the manuscript is required, the authors must submit within three weeks of the request. Authors should expect to participate in at least two rounds of review/revisions during the peer review process.
This Journal uses a double-blind review process, which means the identities of the authors are concealed from the reviewers, and vice versa. To facilitate this, authors must strictly adhere to our instructions for “Blinding for Peer Review” for Original Research, Reviews, Short Reports, Case Reports and Perspectives manuscript types. Manuscripts that do not follow our instructions will be returned to the author for proper blinding, which will delay the peer review process. For information about our peer review policies, visit our “About CANDJ” page.
CANDJ follows the International Committee of Medical Journal Editors’ (ICMJE) Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, which can be found at http://www.icmje.org/. Authors should refer to ICMJE’s “Preparing a Manuscript for Submission to a Medical Journal” guidelines in addition to the guidelines provided below.
- Blinding for Peer Review
- General Format and Presentation
- Title Page
- Abstract and Key Words
- Tweetable Abstract (Optional)
Blinding for Peer Review
This Journal uses double-blind review, which means that the author identities are concealed from the reviewers, and vice versa, throughout the review process.
To facilitate this, authors need to ensure their manuscripts are prepared in a way that does not give away their identity. To help with this preparation please ensure the following are uploaded as two separate files when submitting Original Research, Reviews, Short Reports, Case Reports and Perspectives to CANDJ:
- A version of the manuscript which has had any information that compromises the anonymity of the author(s) removed or anonymized. This version will be sent to the peer reviewers.
- A separate title page which includes any removed or anonymized material, along with other journal requirements. This will not be sent to the peer reviewers. Editorial, Guest Editorials, Commentaries, Position Statements, and Letters to the Editor do not require blinding.
Additional Information to Help Prepare the Blinded Manuscript
There are steps that need to be taken to ensure the manuscript is correctly prepared for double-blind peer review. To assist with this process the key items that need to be observed, where applicable, are as follows:
- Remove identifying information including (but not limited to):
- author names
- author institution details
- author contact details
- ethics approval statements that refer to a specific institution o the names of institutions, participants, or geographic locations involved in studies
- Use the third person to refer to any work previously undertaken by the author(s). For example, replace any phrases like “as we have shown before” with “… has been shown before.” In the list of references treat this type of citation information like any other citation (i.e., do not anonymize it).
- Ensure that figures and tables do not contain any author or affiliation related identifiers.
- Ensure that any references to funding sources are removed.
- Anonymize the trial registration number and date.
- Do not include acknowledgments, funding statements, or conflict of interest statements; this is instead included on the title page.
- Remove identifying information from file names and document properties using Document Inspector.
Where relevant, identifying information should be removed and replaced with “[Anonymized for Peer Review].”
General Format and Presentation
Write the body of the manuscript as concisely as possible, adhering to the suggested word limits specified for the given manuscript type.
For section and subsection headings, please use the heading styles built into your word processing template.
LEVEL ONE HEADING
Level 2 Heading
Level 3 Heading
If further divisions of the text are required, use inline headings:
In-line Heading Level One: Paragraph text ....
In-line Heading Level Two: Paragraph text ....
To facilitate the review process, manuscripts must be in Microsoft Word format. Use a common typeface such as Verdana, Arial, Helvetica, or Times in 11 or 12 points. Special or mathematical characters and Greek letters that are not on a standard keyboard must be created by using the Symbol font. Pages should be consecutively numbered, beginning with “1”.
Focus on the content rather than the look of a submission. Simpler is always better. During the copyediting process all extraneous formatting will, in any case, be stripped from the file to ensure smooth intake into the layout program used by the typesetter.
All manuscript submissions must contain the following items, when applicable:
- Title page
- Abstract and Key Words
- Tweetable Abstract (Optional)
- Text (do not embed figures or tables within the text; tables are placed at the end of the text and figures are uploaded as separate submission files)
- References (prepared according to journal style)
- Figure legends
- Appendices (if applicable)
The linked sections below provide further instructions for preparation of these items.
The title page, which is not sent out for peer review, should include:
- The title of the article.
- The full names of the authors (written as full name, initial(s), and surname), with highest academic degree(s) attained. Omit “candidate,” “fellow,” and “diplomate” designations, but include “registered” designations. Note: Authors are responsible for ensuring the designations/titles provided comply with any regulatory requirements in the jurisdiction in which they are regulated/licensed, or, in unregulated jurisdictions, comply with any applicable health legislation.
- The affiliation or affiliations for each author. For each affiliation, include the name of the department (if any), the institution, the city, and the province (if Canada, using the official postal abbreviation) or the state (if applicable) and country where the work was done. Link the authors to their designations using superscript numbers.
- A shortened version of the title for use as a running header (no more than 60 characters).
- The usual full name of the corresponding author, with postal address, e-mail address, and telephone number(s).
- The heading “Statements of Declaration” and include the following statements:
- Authorship Contribution: This text should contain a statement by the corresponding author that each author meets all four criteria for authorship recommended by the International Committee of Medical Journal Editors (ICMJE), that all individuals who meet these criteria are listed as authors, and that all coauthors have reviewed and approved the manuscript prior to submission.
- Acknowledgments (If none to declare then list “Not Applicable”)
- Funding (even if there is no funding to declare)
- Conflicts of Interest Disclosure (even if there are none to declare)
Abstract and Key Words
For Original Research and Review Articles (Systematic and Meta-Analyses), include a structured abstract of no more than 250 words. Use these subheadings, or the headings suggested by the relevant reporting guidelines:
- Background (or Objective)
- Conclusions (or Summary)
- Trial Registration (for clinical trials only; include registry and number)
For Short Reports, Case Reports, Perspectives, Narrative Review Articles and Position Statements, include an unstructured abstract of no more than 250 words that summarizes the objective, main points, and conclusions of the article.
Do not include abstracts for Editorials, Guest Editorials, Commentaries and Letters to the Editor.
An abstract is often presented separately from the article, so it must be able to stand alone. The abstract should not contain any undefined abbreviations or references.
After the abstract, list up to eight key words or phrases for indexing. The key words should be different from those used in the title. A list of key words is required for all articles, except for Editorials, Commentaries and Letters to the Editor. Present the key words in one paragraph, separated by semi-colons, with a period at the end. Only the first key word should be capitalized.
Authors are requested to provide a tweetable abstract, along with the hashtags or accounts they suggest that the Journal mention when sharing their work. The tweet should summarize the key message or findings of the article and include any relevant hashtags. Tweets can be up to a maximum of 280 characters; however we recommend approximately 180 characters or less for a tweetable abstract. We also encourage authors to use appropriate hashtags and @mentioning authors, institution, funders, etc. to help increase the discoverability of a tweet. Refer to the Social Media section for more information.
Organize the text using the applicable structure from the list set out here. Acknowledgements, Conflict of Interest Disclosures, and Funding Statements are to be included in the title page for blinding purposes. The statements are to be inserted before the references should your manuscript be accepted for publication.
Original Research Articles
Introduction, Methods, Results, Discussion, Conclusions, References, Figure Legends, and Tables. Additional descriptive subheadings may be used if appropriate.
For meta-analyses and systematic reviews: Introduction, Methods, Results, Discussion, Conclusions, References, Figure Legends, and Tables. Additional descriptive subheadings may be used if appropriate.
For narrative reviews: Introduction, Text (may include Results and Discussion), Conclusions or Summary, References, Figure Legends, and Tables. The headings for narrative reviews will vary with the topic.
Introduction, Methods, Results, Discussion, References, Figure Legends, and Tables. Authors may insert a short summary/conclusion section following the discussion section if they wish. In some cases, results and discussions sections may more appropriately be combined than separated (at the author’s discretion).
Introduction, Case Description, Discussion, References, Figure Legends, and Tables. Authors may insert a short summary/conclusion section following the discussion section if they wish.
Introduction, Text (include headings in the text body), Conclusions or Summary, References, Figure Legends, and Tables.
Commentaries and Guest Editorials
Text (with limited or no subheadings), References, Figures Legends, and Tables.
Letters to the Editor
Text (with limited or no subheadings) and References.
Use abbreviations sparingly and keep to those commonly used in the field. All acronyms and initialisms are to be spelled out on first use in the abstract, the text, and in each table or figure, with the abbreviation following in parentheses. If the term is repeated less than five times in the text, all instances must be spelled out. Abbreviations used in the body of the article should be indicated in the abstract, tables, and figures, even if they are used only once or twice in these sections, spelling out the first instance.
Do not explain abbreviations for units of measurement [3 mL, not 3 milliliters (mL)] or standard scientific symbols. Abbreviate names of tests and procedures that are better known by their abbreviations than by the full name. Abbreviate units of measurement when they appear with numerals (measured in milliliters, but 10 mL). Use abbreviations in figures and tables to save space. Explain all abbreviations used in the figure legend or table footnote.
Units of Measurement
Use SI units throughout. When units other than SI units are widely used, they can be indicated in parentheses after the SI unit. In tables, specify the units for a column or row in the column or row stub rather than in every entry in the column or row.
Proprietary and Generic Names
Generic names must be used for all drugs and natural health products. Include the proprietary name in the following cases: if it is more commonly known than the generic name; to differentiate among drug forms; if a specific trade preparation was used in a study or involved in an adverse effect. If the proprietary name is used, the name and location of the manufacturer must be given in parentheses in the text. Herbal medicines can be referred to by their common name but must also include a Latin binomial name to ensure accurate interpretation by readers. Instruments and medical devices may be referred to by proprietary name; the name and location of the manufacturers must be given in parentheses in the text.
Use of English Language
All papers are published in English, and authors who are not fluent in English are advised to seek editorial help before submitting their papers. This will help to ensure that the academic content of the paper is fully understood by the Journal’s editors and reviewers.
Use Canadian spelling. In this context, “Canadian” spelling means using “–our” and “–re” word endings (“rigour,” “centre”) and doubled consonants in most verb forms (“signalling,” “modelling”). However, “–ize” and “–yze” are the preferred verb endings (“characterize” not “characterise” and “analyze” not “analyse”), and diphthongs are not used (for example, “hemoglobin” not “haemoglobin” and “diarrhea” not “diarrhoea”). Use the serial comma (sometimes called the “Oxford” comma).
Certain symbols that are frequently used in medical publications (Greek and mathematical symbols primarily) do not usually import correctly from word processing files into page layout programs. Authors can feel free to use these symbols, but during the copyediting process, they will be changed into codes that the page compositor can locate in a search-and-replace operation to drop the correct symbols into the laid-out pages. On no account should the codes added by the copyeditor be altered by the author during the author’s copyedit review step. (Some examples of these codes are “xxa” for alpha, “xx>” for “greater than or equals,” and “xxby” for the multiplication symbol.)
CANDJ adheres to the American Medical Association (AMA) reference style (11th edition). Please review the guidelines on AMA to ensure your manuscript conforms to this reference style.
- The accuracy of references is the responsibility of the author(s). Please ensure that every reference cited in the text is also present in the reference list (and vice versa).
- To allow us to create links to abstracting and indexing services, Crossref, PubMed Central and PubMed, please ensure that data provided in the references are correct.
- List all authors and/or editors up to 6; if more than 6, list the first 3 followed by "et al."
- Use journal abbreviations as provided by PubMed/Medline. An authoritative list of journal title abbreviations can be found online by searching the National Library of Medicine Catalogue: http://www.ncbi.nlm.nih.gov/nlmcatalog/journals.
- In article titles, capitalize only the first letter of the first word, proper names, and abbreviations that are ordinarily capitalized in the reference.
- Include citations of unpublished material in the text, not in the references [for example, papers presented orally at a meeting; unpublished work (personal communications, papers in preparation and not yet accepted for publication)].
- When available, the use of the DOI is preferred over URL. A DOI is guaranteed to never change and can therefore use as a permanent link to any electronic article. As per Crossref’s display guidelines, DOIs are always to be displayed as a full URL link in the form https://doi.org/10.xxxx/xxxxx, and not preceded by “doi:” or “DOI:”. If a DOI is listed instead of a URL, it is not necessary to include the date accessed.
- Number the reference list consecutively, using Arabic numerals, in the order in which the references are first cited in the text. Citations appearing in tables and figures must fit into the numbering sequence from the point at which the table or figure is first mentioned in the text.
Citing References in Text
- Use superscript numbers within text, without parentheses.
- The superscript number is inserted into the document immediately next to the fact, concept, or quotation being cited.
- Superscript reference numbers are placed after periods and commas and before colons and semicolons. Example:
- Some physicians choose to store prescription pads in locked cabinets8; others keep them in their coat pocket at all times.9
- Reference numbers should be in sequence.
- Use a hyphen to join the first and last numbers of a closed series.
- Use commas without spaces to separate other parts of a multiple citation.
- In narrative citations, where you mention the author's names as part of the sentence, place the reference number next to the author's names. For example: Research conducted by Smith7 showed a correlation between...
- If a reference is used multiple times in one paper, use the same number throughout.
For guidance on how to use the AMA style guide, refer to https://researchguides.uic.edu/ld.php?content_id=54861424 and https://libguides.usc.edu/ld.php?content_id=54130825. Also refer to samples of common reference formats below.
Print Journal Article
Format: Author(s). Article title. Abbreviated Journal Name. Year;volume(issue):pages.
Example: Nathan JP, Grossman S. Professional reading habits of pharmacists attending 2 educational seminars in New York City. J Pharm Practice. 2012;25(6):600-605.
Online Journal Article (URL Only)
Format: Author(s). Article title. Abbreviated Journal Name. Year;volume(issue):pages. Accessed date. URL (no period after the URL)
Some online journals do not have page numbers. Use the article number instead.
Example: Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2001;286(22):2815-2822. Accessed April 4, 2007. https://jamanetwork.com/journals/jama/fullarticle/194457
Online Journal Article (DOI)
Format: Author(s). Article title. Abbreviated Journal Name. Year;volume(issue):pages. DOI (displayed as a full URL link in the form https://doi.org/10.xxxx/xxxxx, and not preceded by “doi:” or “DOI:”)
Example: Propper L, Cumby J, Uher R, et al. Disruptive mood dysregulation disorder in offspring of parents with depression and bipolar disorder. Br J Psychiatry. June 2017;210(6):408-412. http://doi.org/10.1192/bjp.bp.117.198754
Online Journal Article (Publish-ahead-of-print)
Format: Author(s). Article title. Abbreviated Journal Name. Published online month day year. DOI
Example:Papastergiou J, Folkins C, Li W. Community pharmacy-based A1c screening: a Canadian model for diabetes care. Int J Pharm Pract. Published online December 16, 2015. https://doi.org/10.1111/ijpp.12228
Format: Author(s). Title of specific item cited (or, if unavailable, give the name of the organization responsible for the site). Name of Web Site. Publication date. Updated date. Accessed date. URL (no period after the URL)
Note: You can only cite the information that is available. You MUST include the date you accessed the site.
- Compound summary for CID 146571: Escitalopram Oxalate. PubChem Compound Database. Accessed April 16, 2016. https://pubchem.ncbi.nlm.nih.gov/compound/146571
- Website with group author and publication date American Heart Association. Is vaping better than smoking? American Heart Association website. Updated October 18, 2018. Accessed April 15, 2020. https://www.heart.org/en/healthy-living/healthy-lifestyle/quitsmoking-tobacco/is-vaping-safer-than-smoking
Authors are asked to keep each table to a reasonable size; very large tables packed with data simply confuse the reader. The same data should not be presented in both a table and a figure.
Tables are to be numbered using Arabic numerals in the order in which they are cited in the article text. Tables should also have a title (above the table) that summarizes the whole table; it should be no longer than 15 words. Every table column and row should be provided with an explanatory title stub, with units of measure applicable to the row or column clearly indicated.
Tables must be formatted using the table tool in a word processing program to ensure that columns of data remain aligned when the file is sent electronically for review. Tables must not be embedded as figures or spreadsheet files.
Table legends follow the table body and should be as concise as possible. Footnotes follow the table legend and should be indicated using superscripted lowercase letters (a, b, c, and so on). Tables (together with their footnotes and legends) should be completely intelligible without reference to the text.
All tables (including their associated title, footnotes, and legends) should appear in consecutive numerical order after the references and any figure legends. All tables will be placed close to their text citations during article layout. All tables must be cited in the article text.
If the table is taken from a copyrighted publication, the author(s) must secure permission from the copyright holder, appropriate credit must be given as a table footnote, and a corresponding reference must appear in the reference section.
Illustrations, pictures, and graphs, should be supplied in the highest quality and in an electronic format that helps us to publish your article in the best way possible. All images MUST be at or above intended display size. The following resolutions are optimal:
- Line drawings, minimum 800 dpi
- Combination (Line Art + Halftone), 600 dpi
- Illustrations and photographs, 300 dpi
Authors should supply electronic versions of the figure content in TIFF or JPEG format. Other formats, such PDFs, may be used, but are not preferred. Drawings made in Microsoft Word and PowerPoint are discouraged, because the display of such drawings varies with the settings of each computer used to view the file. There is no guarantee that such figures will reproduce exactly as intended by the author.
Save each figure in a separate file without its title or legend and use simple file-naming conventions (for example, Figure 1, Figure 2A).
There is no cost for publishing full colour graphics.
All figures should be individually uploaded in the online submission process, and not embedded within the manuscript.
Figures are to be numbered using Arabic numerals (1, 2, 3, and so on) in the order in which they are cited in the article text. If a figure has several panels, each panel should be identified using an uppercase alphabetic character (A, B, C, and so on). Each figure should have a title and an explanatory legend that clearly identifies the meaning of any symbols, arrows, numbers, or abbreviations used in the illustration. The legend should permit the figure to be understood without reference to the text.
Title and legend information for each figure should be included with the article text, grouped and placed at the end of the manuscript, after the reference list. All figures will be placed close to their text citations during article layout. Make sure that each figure is cited in the article text.
Please note it is the responsibility of the author(s) to obtain permission from the copyright holder(s) to reproduce figures, tables, or excerpted text, that have previously been published elsewhere. This includes a full bibliographic reference to the original publication and an acknowledgement that the material is reproduced with permission from the rights owner. Authors are responsible for any fees that may be incurred by securing permission to reproduce or adapt material from other published sources. Permission should be obtained prior to submission, and evidence of permission should be supplied by the author at the time of submission. Any material received without such evidence will be assumed to originate from the authors.
EDITORIAL POLICIES FOR AUTHORS
CANDJ follows the International Committee of Medical Journal Editors’ (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals, which can be found at http://www.icmje.org/. In addition, CANDJ has specific requirements for the articles it publishes.
Criteria for Authorship
Only those persons who contributed directly to the intellectual content of the manuscript should be listed as authors. Based on the ICMJE recommendations, authors must meet all the following criteria:
- Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
- Drafting the work or revising it critically for important intellectual content; AND
- Final approval of the version to be published; AND
- Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Holding positions of administrative leadership, contributing patients, and collecting and assembling data, are not, by themselves, criteria for authorship. Other persons who have made substantial, direct contributions to the work but cannot be considered authors should be listed in the Acknowledgments section.
When a large multi-author group has conducted the work, the group ideally should decide who will be an author before the work is started and confirm who is an author before submitting the manuscript for publication. All members of the group named as authors should meet all four criteria for authorship, including approval of the final manuscript, and they should be able to take public responsibility for the work and should have full confidence in the accuracy and integrity of the work of other group authors. They will also be expected as individuals to provide conflict-of-interest disclosures.
When a large, multi-center group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship defined above. When submitting a group author manuscript, the corresponding author should clearly indicate the preferred citation and should clearly identify all individual authors as well as the group name. Other members of the group should be listed in the acknowledgements.
Role of the Corresponding Author
The corresponding author is the one individual who takes primary responsibility for communication with the Journal during the manuscript submission, peer review, and publication process. Only one author can be the corresponding author. The role of the corresponding author is to:
- meet submission requirements and submit the manuscript to the Journal
- ensure all authors have reviewed and approved the final version of the manuscript prior to submission
- ensure that all of the Journal’s administrative requirements are met – including submission of all required forms
- ensure the Journal’s ethical policies are met by all authors
- distribute decision letters, reviewer comments, and other messages from the Journal, and distribute proofs among co-authors for review
- return corrections and ensure that all authors approve each version of the article
- be available after publication to respond to critiques of the work and cooperate with any requests from the Journal for data or additional information should questions about the paper arise after publication.
Authors should identify their institution(s) as the facility where the work was performed and executed. Changes in an author’s affiliation after the work was completed but prior to the submission or publication of the manuscript should be noted by including an asterisk as a superscript to the name in the author listing, as well as a corresponding footnote on the title page indicating “Current Affiliation” listing the new affiliation. Corrections to affiliations or contact information due to relocation after publication is not permitted.
Changes to Authorship
Authors should carefully consider the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion, or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the Editor. To request a change, the Editor must receive the following from the corresponding author: (1) the reason for the change in author list and (2) written confirmation (email or letter) from all authors that they agree with the addition, removal, or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Only in exceptional circumstances will the Editor consider the addition, deletion, or rearrangement of authors after the manuscript has been accepted. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
Duplicate Publication and Concurrent Submission
Duplicate publication is publication of a paper that overlaps substantially with one already published, without clear, visible reference to the previous publication. On the title page, give full details on any possible previous or duplicate publication of any content of the paper. Any reference to or use of previously published material must be explicitly acknowledged in the manuscript and the authors must obtain permissions where necessary. Previous publication of a small fraction of the content of a paper does not necessarily preclude it from being published, but the Editors need information about previous publication when deciding how to use space in the Journal efficiently; they regard failure of full disclosure by authors of possible prior publication as a breach of scientific ethics. Please send a copy of any document that might be considered a previous publication.
Duplicate or redundant submission is the same manuscript (or the same data) that is submitted to different journals at the same time. International copyright laws, ethical conduct, and cost-effective use of resources require that readers can be assured that what they are reading is original. Manuscripts that are submitted to CANDJ should not have been previously published or under consideration elsewhere.
Authors should be advised that CAND is a member of Similarity Check, a plagiarism detection initiative by Crossref and iThenticate. The CANDJ uses software to randomly scan accepted articles for duplication of text from previously published sources. Editors may also initiate a scan of any submitted manuscript during the review process if duplicate publication or text recycling (self-plagiarism of an author’s own publications) is suspected. Any article displaying more than a 15% level of duplication (excluding references) will be investigated and further action will be decided upon by the Editors on a case-by-case basis. Editors handle cases according to the guidelines outlined by the Committee on Publication Ethics (COPE) (http://publicationethics.org/) for duplicate publication and plagiarism.
We also encourage authors and researchers to use iThenticate to screen their work before submission by visiting http://www.ithenticate.com/.
Contributors who do not meet the criteria for authorship should be listed in an Acknowledgments section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Because acknowledgment may imply endorsement by acknowledged individuals of a study’s data and conclusions, the corresponding author must obtain written permission to be acknowledged from all acknowledged individuals.
Any acknowledgments should appear within the title page of your manuscript, to maintain the integrity of the double-blind review. If you do not have anyone to acknowledge, please write "Not applicable" in this section. The acknowledgments statement will be published in the article prior to the references, along with the Funding and Conflicts of Interest Disclosure(s) statements.
CANDJ requires all authors to declare the sources of funding that supported the conduct of the research and/or preparation of their manuscript. This includes financial or in-kind support from funding bodies, sponsors, industry, and other collaborators. The role of the funding organization, if any, in the collection of data, its analysis and interpretation, in the writing of the manuscript, and in the right to approve or disapprove publication of the finished manuscript must be briefly described. If the funding source(s) had no such involvement then this should be stated in the statement as follows “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript”. If the article did not receive funding, this should also be stated as “This research did not receive external funding”. Please include this information under a separate heading entitled ‘Funding’ directly after any Acknowledgements and Conflicts of Interest Disclosure (if applicable) within the title page of your manuscript, to maintain the integrity of the double-blind review. The funding statement will be published with the article directly after the Acknowledgements and Conflicts of Interest Disclosure(s) and prior to the references.
Conflicts of Interest
Public trust in the scientific process and the credibility of published articles depend in part on how transparently conflicts of interest are handled during the planning, implementation, writing, peer review, editing, and publication of scientific work. A conflict of interest exists when professional judgment concerning a primary interest (such as patients' welfare or the validity of research) may be influenced by a secondary interest (such as financial gain). Perceptions of conflict of interest are as important as actual conflicts of interest.
Financial relationships are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and of science itself. However, conflicts can occur for other reasons, such as personal relationships or rivalries, academic competition, and intellectual beliefs. Agreements between authors and study sponsors that interfere with the authors’ access to all of a study’s data or that interfere with their ability to analyze and interpret the data and to prepare and publish manuscripts independently may represent conflicts of interest and should be avoided.
In the interest of transparency, authors are required to disclose all relationships/activities/interests listed below that are related to the content of your manuscript. As per ICMJE, “related” means any relation with for-profit or not-for-profit third parties whose interests may be affected by the content of the manuscript. Disclosure represents a commitment to transparency and does not necessarily indicate a bias. If you are in doubt about whether to list a relationship/activity/interest, it is preferable that you do so. The time frame for disclosure is within the past 36 months.
- Grants or contracts from any entity
- Royalties or licenses
- Consulting fees
- Payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events
- Payment for expert testimony
- Support for attending meetings and/or travel
- Patents planned, issued or pending
- Participation on a Data Safety Monitoring Board or Advisory Board
- Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid
- Stock or stock options
- Receipt of equipment, materials, drugs, medical writing, gifts or other services
- Other financial or non-financial interests
All authors must disclose if any conflict of interest exists or declare if they have none. The Conflicts of Interest Disclosure is required for all manuscripts and will be published. It is the responsibility of the corresponding author to ensure that all co-authors adhere to this policy and to confirm wheth-er they have any conflicts to declare.
The following statement must be included in the title page of your manuscript under the heading “Conflicts of Interest Disclosure”.
“I/We have read and understood the CAND Journal’s policy on conflicts of interest disclosure and declare the following interests: [list them or state that you have none].”
No competing interests
“We have read and understood the CAND Journal’s policy on disclosing conflicts of interest and declare that we have none”
Competing interests disclosed
“We have read and understood the CAND Journal’s policy on disclosing conflicts of interest and declare the following interests: AA has received speaker fees from BBB company. CC has received fees as an advisory board member for DDD company. EE’s institution receives funding from FFF Company for a trial in which he is co-investigator."
In order to assist authors in the formation of their disclosure statements, and to help standardize authors’ disclosures across journals, we recommend that all authors download and complete a copy of the ICMJE disclosure form, which is available from http://www.icmje.org/disclosure-of-interest/. It is not mandatory to complete this form but encouraged. A summary statement derived from the information entered in this form can be provided to the corresponding author.
Research Ethics and Informed Consent
In addition to CANDJ’s policies below, please also refer to the ICMJE Recommendations for the Protection of Research Participants. Editors reserve the right to reject any submission that does not meet these requirements.
Human and Animal Rights
All investigators should ensure that the planning conduct and reporting of human research are in accordance with the Helsinki Declaration as revised in 2013. All authors should seek approval to conduct research from an independent local, regional or national review body (e.g., ethics committee, institutional review board). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the local, regional or national review body explicitly approved the doubtful aspects of the study. For those investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Helsinki must be followed. When reporting experiments on animals, all research submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. Studies involving animals must be conducted and reported according to internationally accepted standards such as the Weatherall report and Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines. We recommend that authors follow the Convention on Biological Diversity (CBD) and the Convention on the International Trade in Endangered Species of Wild Fauna and Flora (CITES).
All papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number. If a study was granted exemption from requiring ethics approval, this must be detailed in the manuscript (including the reasons for the exemption). The statement should be anonymized for double-blind peer review.
If concerns in the conduct of research are discovered after publication, the Journal staff will investigate and, where appropriate, issue a correction or retraction. The Journal reserves the right to contact the author’s institution, ethics committee or other appropriate body in relation to these concerns.
All individuals have a right to privacy that must not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, must not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. For manuscripts that include any personal information and/or images of patients, authors must obtain signed informed consent to publish from patients (or their relatives/guardians) before submitting to CANDJ. If identifying characteristics are altered to protect anonymity, authors should provide assurance that the alterations do not distort the scientific purpose. In some cases, complete anonymity is difficult to achieve, and informed consent to publish must be obtained if there is any doubt. The process of obtaining consent to publish includes sharing the article with the individual (or whoever is consenting on their behalf), so that they are fully aware of the content of the article before it is published. Authors must disclose to these participants that the published content will be available via the Internet and might be available as well in print after publication and in sublicensed and reprinted versions (including translations). When appropriate, authors must state in the Methods section the procedure used to ensure adherence to ethical guidelines on informed consent and should affirm that written and signed informed consent to publish was obtained.
If your manuscript contains a case description of an individual patient or case series, you must confirm on submission that you have obtained fully informed, voluntary, and written consent to publish from the patient(s). If a patient is deceased or incapable of providing informed consent, you must have obtained consent from their next-of-kin, beneficiary, or legal guardian. Information on informed consent must be described in the case description of the article.
Please do not submit the patient’s actual written informed consent with your article, as this breaches the patient’s confidentiality. The consent must be stored and archived by the authors/investigators themselves. A sample of the consent letter may be uploaded with your submission as a separate file.
Authors of articles submitted to CANDJ may choose to share their research data that supports the results stated in the manuscript, unless prevented by ethical, legal, privacy or confidentiality matters. Authors wishing to do so may deposit their data in a publicly accessible repository. Authors should ensure that data shared are in accordance with consent provided by participants on the use of confidential data. When data is available in a publicly accessible repository, a data availability statement should be included in the manuscript under a separate heading labelled “Data Availability Statement” in the Methods section. This should, wherever possible, include a link to and citation of any datasets analyzed or generated in the study.
Citation format of dataset in the reference list:
[dataset] Authors. Year. Dataset title; Data repository or archive name; Version (if any); Persistent identifier (eg. DOI).
Sample Data Availability Statement if included in public repository:
The data presented in this study are openly available in [repository name] at [doi], reference number [reference number].
NOTE: As per ICMJE guidelines, data sharing is a requirement for Clinical Trials submissions. See our “Clinical Trials” section for details.
There are several reporting guidelines available for different types of studies. Authors are expected to adhere to the minimum reporting guidelines hosted by the EQUATOR Network when preparing their manuscript. We have outlined some guidelines below, but for the full list visit the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) website. The EQUATOR wizard can help you identify the appropriate guideline, as well as the different extensions. Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.
The ICMJE defines a clinical trial as any research project that prospectively assigns people or a group of people to an intervention, with or without concurrent comparison or control groups, to study the relationship between a health-related intervention and a health outcome. CANDJ follows and endorses the ICMJE’s clinical trial registration policy. The trial registry name and URL, and registration number must be included at the end of the abstract.
Authors of randomized trials are encouraged to adhere to CONSORT guidelines appropriate to their trial design and refer to one of the official CONSORT extensions (http://www.consort-statement.org/extensions), when applicable. The manuscript should include a CONSORT flow diagram as a figure. The CONSORT checklist should be completed and submitted with the manuscript as a separate support file. To help ensure the study is appropriately indexed, authors should use the word "randomized" in the title.
The ICMJE also requires the inclusion of a data sharing statement. All clinical trials submissions to the Journal must include a data sharing statement as a separate heading in the methods section.
Observational studies including case control, cohort, and cross-sectional studies. Authors are en-couraged to adhere to the STROBE Statement and may optionally include a completed checklist as a separate supporting file.
Systematic Reviews and Meta-Analyses
Reports of systematic reviews and meta-analyses should adhere to the PRISMA Statement or alternative guidelines appropriate to the study design and include the flow diagram within the manuscript as a figure. It is recommended to include a completed checklist as a separate supporting file, but it is not required.
The CARE guidelines address completeness, transparency, and data analysis relevant to the reporting in case reports and point-of-care data. It is recommended to include a completed checklist as a separate supporting file, but it is not required.
Authors of studies including animals are encouraged to adhere to the ARRIVE guidelines. It is recommended to include a completed checklist as a separate supporting file, but it is not required.
PUBLICATION ETHICS AND POLICIES
CANDJ follows the Committee on Publication Ethics (COPE) core-practices. In addition, the Journal follows ICMJE’s Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals, and as such it is expected of authors, reviewers and editors that they follow the best-practice guidelines on ethical behaviour contained within.
Appeals and Complaints
CANDJ follows the Committee on Publication Ethics (COPE) guidelines on appeals to journal editor decisions and complaints about a journal's editorial management of the peer review process.
The Journal permits genuine appeals to Editorial decisions within 30 days of the decision notification. An author may appeal a decision by following the steps below:
- Send a rebuttal letter to the assigned Editor by email. Your letter should explain clearly why you disagree with the decision on your manuscript. Please provide specific responses to any of the Editor’s and/or reviewers' comments that contributed to the reject decision. Other items that may be included in your rebuttal letter are:
- new information or data that you would like the Journal to take into consideration.
- evidence if you believe a reviewer has made errors in their assessment of your manuscript.
- evidence if you believe a reviewer may have a conflict of interest.
- The Editor will consider your appeal. All appeal requests are handled on a case-by-case basis and the Editorial team’s decision is final.
- If your appeal is granted, the following steps will occur:
- Your manuscript will undergo further assessment by an independent reviewer.
- The Editors will make a final decision on your manuscript.
Where you, as an author, wish to comment or place a complaint on aspects of the Journal's editorial management or processes, the complaint should in first instance be handled by the Editor-in-Chief. If they are the subject of the complaint, please approach the Associate Editor.
The Editors of CANDJ enforce a rigorous peer-review process along with strict Editorial Policies and standards to ensure the works published in the Journal are of high scientific quality and contribute to scholarly publishing. Unfortunately, cases of plagiarism, data falsification, undisclosed conflicts of interest, inappropriate authorship credit, and other issues do arise. The Journal’s Editors take such publishing ethics issues very seriously.
In the event that the Editorial Staff is made aware of any allegation of research and publication misconduct relating to a published article in the CANDJ, the Journal will follow the Committee on Publication Ethics (COPE) guidelines in dealing with allegations. If after an investigation there are valid concerns, the authors will be contacted and given an opportunity to address the issue. The Editorial Staff will discuss the suspected cases, in consultation with the CAND, and reach a decision. Authors who are found to have engaged in scientific misconduct will be removed from further association with the Journal (as an Editor, Reviewer and/or Author) and reported to their institution.
Corrections and Retractions
When errors are identified in published articles, the Editor will consider what action is required in consultation with the CAND and/or Publishing Partner. Amendments (if actionable) will be published through a formal online notice since they affect the publication record and/or the scientific accuracy of published information. The online article is part of the published record, and the original published version is therefore maintained. For peer-reviewed material, the amendments fall into the following categories:
Corrigendum (Author Errors): Author corrections will be judged on their relevance to readers and their importance for the published record and ethical responsibilities. Author corrections are published after discussion among the Editorial Staff and publishing team. The Journal will not usually publish a correction that does not affect the contribution in a significant way or if the issue does not considerably impair the reader's understanding of the contribution, such as a spelling mistake or grammatical error. The erratum notice will be published and made free to view in a journal issue and linked to the article of record that it corrects.
Erratum (Journal Errors): Includes mistakes introduced by the Journal in production. Errata are generally not published for simple, obvious typographical errors, but are published when the error is significant (ie. spelling of author name is incorrect). The erratum notice will be published and made free to view in a journal issue and linked to the article of record that it corrects.
Addendum: Includes an editor’s note or editorial expression of concern, which provides additional information about a paper that is crucial to the reader's understanding of the published contribution. The addendum may be published in cases where we receive inadequate evidence of misconduct, investigation has not been or would not be impartial or conclusive, or an investigation is underway and the decision may not be made for a significant amount of time. Dependent on the urgency, the addendum notice may immediately be linked to the published article that it refers to, prior to being officially published in a journal issue.
Retraction: The Journal will consider issuing a retraction notice if we have clear evidence that the published findings are unreliable because of misconduct or honest author error, the findings have been published elsewhere without the appropriate permissions or justification, the publication constitutes plagiarism, and/or the publication reports unethical research. The article of record will be digitally watermarked “RETRACTED” and the retraction notice will be immediately linked to the published article that it refers to, prior to being officially published in a journal issue. The Journal will consider issuing a retraction notice if we have clear evidence that the published findings are unreliable because of misconduct or honest author error, the findings have been published elsewhere without the appropriate permissions or justification, the publication constitutes plagiarism, and/or the publication reports unethical research. The article of record will be digitally watermarked “RETRACTED” and the retraction notice will be immediately linked to the published article that it refers to, prior to being officially published in a journal issue.
There are no submission fees, publication fees or page charges for this journal.
Authors submitting manuscripts to CANDJ do so with the understanding that if a manuscript is accepted, the copyright of the article, including the right to reproduce the article in all forms and media, shall be assigned exclusively to the Canadian Association of Naturopathic Doctors (CAND). The corresponding author will be required to sign a Copyright Transfer Agreement on behalf of all authors. This must be completed and returned to SG Publishing Inc. (Publishing Partner) before an accepted article can be published in the Journal. CANDJ allows authors to retain a number of nonexclusive rights to their published article. See the Copyright Transfer Agreement or Author Rights for details.
As an author, you are granted specific rights for a large number of author uses, which are granted and permitted without the need to obtain specific permission from the copyright holder, the Canadian Association of Naturopathic Doctors (CAND). The article must be properly cited (i.e., author name(s), journal name, copyright year, volume number, inclusive pages, and copyright holder). These author rights are granted and apply only to articles for which you are named as the author or co-author. The author rights include:
- The right to reuse figures or tables created by the authors and contained in the article in other works created by them, provided it is not for commercial use;
- The right to include the article in full or in part in a thesis or dissertation, provided that this not published commercially;
- The right to make copies of the article for your own personal use (non-commercial and non-profit), including distributing copies for your own teaching use;
- The right to reproduce, and permit any academic institution where you work at the time, to reproduce and distribute copies of the article for the purpose of teaching;
- The right to make copies and distribute copies of the article to research colleagues, for the personal use by such colleagues (but not commercially or mass distribution (e.g. Email list);
- Patent and trademark rights and rights to any process or procedure described in the article;
- The right to use the article or any part thereof in a printed compilation of works of the author, such as collected writings or lecture notes (following publication of the article in the Journal and provided that it is not for commercial use); AND
- The right to reuse portions or excerpts in other works provided there is full acknowledgment of its original publication.
All CANDJ articles are made freely accessible online 12 months after publication on the Journal’s website. Authors are permitted to self-archive the accepted manuscript (the version post-peer review, but prior to copyediting and typesetting) on their own personal website and/or in their funder or institutional repositories, and/or not for profit subject-based repositories such as PubMed Central, for public release 12 months after first publication. Authors must cite the publication reference and full DOI number on the first page of any deposited version and provide a link from it to the URL of the published article on the Journal's website. Please note that the accepted manuscript may not be released under a Creative Commons license. The author may not use the final published PDF version without obtaining permission from the CAND.
As a way of encouraging ongoing discussion within the field, the Journal will share published articles via its social media channels. To assist with our efforts of broadening the reach of articles published in the CANDJ, Authors are encouraged to provide a tweetable abstract for the Journal to use when sharing their article via Twitter. It should summarize the key message or findings of the article and include any relevant hashtags. Tweets can be up to a maximum of 280 characters; however we recommend approximately 180 characters or less for a tweetable abstract as shorter tweets generally receive better engagement. Using appropriate hashtags and @mentioning authors, institution, funders, etc. is an excellent way to increase the discoverability of a tweet mentioning their article. Authors are requested to provide a tweetable abstract, along with the hashtags or accounts they suggest that the Journal mention when sharing their work. Learn more within our manuscript preparation guidelines here.
Authors that provide social media handles benefit from the Journal’s promotions, expanding their reach well beyond the current publication. Please note that providing a Twitter handle for publication is entirely optional. If authors are not comfortable with the Journal promoting their article along with their personal Twitter handle(s) then please do not supply them. Authors that have any queries or concerns about sharing their article via social media may contact firstname.lastname@example.org.